Indian students pursuing medical degrees in Georgia face uncertainty over their eligibility to practise in India following a recent clarification by the National Medical Commission on the country's junior doctor status.
PAPs can reduce expenditure by 30 to 60 per cent for some expensive immunotherapies and targeted therapies.
India's drug price regulator, the National Pharmaceutical Pricing Authority (NPPA), has significantly reduced the maximum retail prices (MRPs) of 543 cancer drug brands and pack sizes, with some reductions reaching up to 93 per cent. However, expensive innovator drugs from multinational corporations, including high-selling Bevacizumab and immunotherapy Keytruda, remain unaffected, highlighting limitations in the price control intervention.
The Supreme Court has questioned the Centre's decision to cap trade margins on anti-cancer drugs at 30 per cent, asking why similar restrictions could not be extended to other medicines and medical consumables, citing glaring disparities between procurement costs and maximum retail prices (MRPs).
The directive comes amid concerns over steep mark-ups on medicines and medical consumables sold at hospital pharmacies.
Large office leases in Mumbai and Delhi-NCR are commanding premium rentals in key micro-locations, driven by a scarcity of quality Grade-A space and sustained occupier demand, according to real estate consultants.
India's apex drug regulator cautioned against antibiotic self-medication and their use for conditions where antibiotic treatment is not clinically indicated, particularly viral infections, the common cold and fever.
CDSCO has warned consumers against using two unauthorised Pakistani whitening creams after finding excessive heavy metals and regulatory violations.
India's student housing shortage is widening, but high land costs, weak rental yields and regulatory hurdles are keeping organised developers away.
Hospital chain Fortis Healthcare has filed a special leave petition in the Supreme Court against a Delhi High Court order directing a forensic audit into the alleged erosion of assets by its former promoters, Malvinder and Shivinder Singh, during enforcement proceedings initiated by Japanese drugmaker Daiichi Sankyo.
Pharma major Lupin is significantly increasing its focus on biosimilars, aiming for a turnover of nearly $500 million from this segment over the next five years, driven by new product launches and expanded presence in key global markets like the US, Europe, and Japan.
Of the 37,448 candidates registered for the Foreign Medical Graduate Examination (FMGE) in June, 36,288 appeared and 4,635 qualified.
The Delhi High Court has mandated a six-month forensic audit into the alleged dissipation of assets by former Fortis promoters Malvinder Mohan Singh and Shivinder Mohan Singh, stemming from enforcement proceedings by Japanese drug major Daiichi Sankyo.
NBEMS will not lower FMGE qualifying standards despite protests.
'Indian private sector hospitals provide quality healthcare at a fraction of the global cost.'
Several Indian cities report a surge in influenza cases, prompting state governments to issue advisories asking people to mask up in public spaces and follow basic respiratory hygiene.
'Having analysed the break up of the hospital billing structure the committee believes that rationalising of room charges needs to be done on an emergent basis.'
Doctors attribute the rise in male infertility to obesity, diabetes, smoking, chronic stress, inadequate sleep and sedentary lifestyles.
'There is no need for panic as there is widespread protective immune memory in the population from vaccination as well as prior infections.'
The move follows reports from several state drug-regulatory authorities indicating misuse and hoarding oral formulations with high ethyl-alcohol concentration, which people use as a substitute for liquor.
